Literature DB >> 33764342

[Vaccination confidence against influenza in Spain: reasons of hesitancy discourses and attitudes in general population and healthcare workers.]

Carmen Olmedo Lucerón1, Aurora Limia Sánchez1, Cristina Santamarina2.   

Abstract

OBJECTIVE: Influenza is a huge public health problem and vaccination is the best prevention tool. Vaccination coverage of target population is still far from the established objectives. The aim was to delve into the most important factors and actors influencing behaviors of influenza vaccine hesitancy in Spain from a qualitative perspective.
METHODS: Qualitative research through one discussion group, three experiential groups and thirteen in-depth interviews was conducted with health professionals and general population in Madrid and Valencia in 2019.
RESULTS: Influenza is considered a common, low-danger disease. Confusion due to misinformation and lack of knowledge and a high fear of vaccine adverse effects has been identified. The different conviction with which professionals recommend the vaccine has emerged, and the low awareness of the transmitting role of the disease was found in general population and professionals.
CONCLUSIONS: The findings of this study suggest the importance and urgency of developing well-structured and coordinated communication strategies, with common key messages and channels adapted to different populations from the deficiencies and needs identified. Strategic work with healthcare professionals is an essential factor in the final decision to get vaccinated against influenza.

Entities:  

Keywords:  Hesitancy; Influenza; Qualitative research; Spain; Vaccine

Mesh:

Substances:

Year:  2021        PMID: 33764342

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  1 in total

1.  A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018-19 season: the Gripómetro.

Authors:  Javier Díez-Domingo; Esther Redondo Margüello; Raúl Ortiz de Lejarazu Leonardo; Ángel Gil de Miguel; José María Guillén Ortega; Jesús Rincón Mora; Federico Martinón-Torres
Journal:  BMC Public Health       Date:  2022-04-25       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.